LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 1657 | 1745 | 5505 | 0.3170 | 0.0227 |
BT-20 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 1657 | 1679 | 5505 | 0.3050 | 0.0055 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 1657 | 1633 | 5505 | 0.2966 | -0.0064 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 1657 | 1624 | 5505 | 0.2950 | -0.0088 |
BT-20 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 1657 | 1711 | 5505 | 0.3108 | 0.0138 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1657 | 742 | 5505 | 0.1348 | -0.2380 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1657 | 1049 | 5505 | 0.1905 | -0.1582 |
BT-20 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1657 | 1113 | 5505 | 0.2022 | -0.1416 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1657 | 1071 | 5505 | 0.1945 | -0.1525 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1657 | 987 | 5505 | 0.1793 | -0.1743 |
BT-20 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1657 | 1277 | 5505 | 0.2319 | -0.0989 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1657 | 5054 | 5505 | 0.9180 | 0.8826 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1657 | 5268 | 5505 | 0.9568 | 0.9382 |
BT-20 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1657 | 5291 | 5505 | 0.9610 | 0.9442 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1657 | 1245 | 5505 | 0.2261 | -0.1073 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1657 | 1316 | 5505 | 0.2390 | -0.0888 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1657 | 1093 | 5505 | 0.1985 | -0.1468 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 1 | F20 | 72 | hr | 1657 | 3580 | 5505 | 0.6502 | 0.4996 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 2 | F20 | 72 | hr | 1657 | 3199 | 5505 | 0.5810 | 0.4005 |
BT-20 | GSK 690693 | 3.33 | uM | LJP5 | 3 | F20 | 72 | hr | 1657 | 3571 | 5505 | 0.6486 | 0.4972 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 1657 | 1085 | 5505 | 0.1971 | -0.1488 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 1657 | 1224 | 5505 | 0.2223 | -0.1127 |
BT-20 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 1657 | 1415 | 5505 | 0.2570 | -0.0631 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 1657 | 2905 | 5505 | 0.5276 | 0.3241 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 2 | B08 | 72 | hr | 1657 | 2351 | 5505 | 0.4270 | 0.1802 |